Trending

pulmonary arterial hypertension

Gilead pays $97m to resolve US illegal kickback claims

Gilead pays $97m to resolve US illegal kickback claims

Gilead has paid $97 million to resolve claims by US authorities that it acted illegally by using a

X

Gilead pays $97m to resolve US illegal kickback claims

https://pharmaphorum.com/news/gilead-pays-97m-to-resolve-us-illegal-kickback-claims/

Moderna broadens R&D scope with Vertex, Chiesi alliances

Moderna broadens R&D scope with Vertex, Chiesi alliances

All eyes may be on Moderna’s COVID-19 vaccine at the moment, but the US biotech hasn’t been idle

X

Moderna broadens R&D scope with Vertex, Chiesi alliances

https://pharmaphorum.com/news/moderna-broadens-rd-scope-with-vertex-chiesi-alliances/

Gilead to take selonsertib into phase 3 in NASH

Gilead to take selonsertib into phase 3 in NASH

But drug flops in two other indications.

X

Gilead to take selonsertib into phase 3 in NASH

https://pharmaphorum.com/news/gilead-take-selonsertib-phase-3-nash/

CONTINUE TO SITE >

Close in 10 seconds

Pharmaphorum.com